Since it has been described that resveratrol’s anti-oxidant and anti-inflammatory properties are associated with protection in ischemia, we hypothesized that resveratrol treatment should not affect GLUT3 up-regulation induced in astrocytes after cerebral ischemia. The gene discussed is SLC2A3; the disease is Cerebral ischemia.